Delivery Order SPE2DB20D2104-SPE2DB25FMZEV
- Not listed
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $2,201.40. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $9,111.37. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,196.24 by the Defense Logistics Agency on August 21, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement with an ultimate completion date of August 22, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $5,882.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Januvia 50 mg tablets (90-count packages). The contract, with an ultimate completion date of July 23, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a contract ceiling value of $50,372.45 and a firm fixed-price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 2, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for Januvia 100 mg tablets (90-count units) on July 28, 2025, with a ceiling value of $2,218.86. This is a firm fixed price, non-set-aside contract with a completion date of July 29, 2025. The award was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count packages) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,942.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for 90 tablets of Januvia 100 mg, a diabetes management medication. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZEVDelivery Order
The Defense Logistics Agency awarded a $2,187.36 delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company's extensive portfolio of DLA contract awards demonstrates its capability to fulfill diverse pharmaceutical requirements, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Januvia, a diabetes management medication, reflects the company's role in supporting the Defense Health Agency and other federal healthcare entities through competitively awarded, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/29/25 |